Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q1 2019 · 10-Q
Revenue$590.00K$590.00K+27.2% vs Q1 2018 Net Income-$2.57M-$2.57MN/M vs Q1 2018 EPS Diluted-$0.04-$0.04N/M vs Q1 2018 Operating Income-$2,563,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,068,000N/M Margins · derivedOperating margin-434.4%−19.1 pt vs Q1 2018
Net margin-434.9%+69.2 pt vs Q1 2018
ended Oct 31, 2018 · filed Dec 13, 2018 · 43 d after period end